Navigation path

Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Glimepirida Parke-Davis and associated names

Product name: Glimepirida Parke-Davis and associated names
Also marketed in the EU under the name(s): Glimepirid Pfizer, Glimepirida Parke-Davis, Glimepiridae Parke-Davis, Glimepiride Pfizer
Active substance: Not available
Indication: Treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2012 Referral EMEA/H/A-29/1338 (2012)8593 of 19/11/2012